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ABSTRACT 
Frustrated from the complex chemistry of the drugs have troubled the researchers in finding the ideal drug. Effective targeted drug delivery 
system has always been the dream. It has also long been a problem for medical researchers i.e., how to get them to the target organ in the body 
and how to control the release of the drug to prevent overdoses. The development of new and complex molecule called Na nosponges is proving 
promising to solve this problem.  
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Introduction 
From the 19th century, the field of medicine has flourished at 
an incredible rate. The discovery of antibiotics, anticancer 
drugs, transplant surgeries and various other forms of 
treatment has allowed humans to survive life-threatening 
diseases and deforming diseases like Polio, and many else. Yet, 
there are still diseases that cannot be treated, which has 
allowed traditional medicine to move into the new direction of 
using nanomedicine. [1] 
An ideal drug therapy is the one which has effective 
concentration of drug at the target site for a specified period of 
time in order to prevent or keep to the minimum, general and 
local side effects. To obtain a desirable therapeutic response, 
the proper amount of drug should be transported and 
delivered to the site of action with subsequent controlled 
release. The distribution of drug to other tissues therefore 
seems rather unnecessary, wasteful and a potential cause of 
toxicity. Targeted drug delivery is the delivery of drug to 
receptor, organ or any part of the body to which one wishes to 
deliver the drug exclusively. 
The first nanoparticles were developed by Peter Paul Speiser 
in the year, 1960. The nanoparticles were used for targeted 
drug therapy. This was an impetus for other research 
developing various carrier systems. At the end of the 20th 
century, nanoparticles were modified to transport of DNA 
fragments into cells by using antibodies [2]. Since then there 
has been a efflux of publications in this area. The publications 
have increased from 10 articles in 1990 to 1200 articles in 
2004, illustrating the snowballing interest in nanomedicine 
[3]. 
Difference between Conventional and 
Nanomedicine 
Study states that, 40% of Food and Drug administration (FDA) 
approved drugs and 90% of the drugs which are under clinical 
trials are poorly soluble. They have low permeability, rapid 
clearance by the body and are toxic to the cells of the body [4]. 
This study has shown that some conventional drugs do not 
suffice to achieve the desired effect. So, drugs are modified 
into carrier systems to achieve a better pharmaceutical profile. 
This is where nanomedicine comes into play. Water insoluble 
drugs can be encapsulated into the hydrophobic domain of 
carrier systems such as micelles, polymeric nanoparticles and 
liposomes. This enables the drug to be carried by a system that 
has a hydrophilic layer, making drug delivery achievable. Due 
to the size of these encapsulated drugs, it provide an 
opportunity for targeting tumours via the enhanced 
permeation and retention effect. The hydrophilic coating 
makes them less predisposed to clearance by the immune 
system, leading to longer time in systemic circulation. These 
carriers can also be modified with ligands or proteins that 
enable therapeutic targeting. Interestingly the application of 
nanocarriers extends to diagnostics as these carriers have 
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been modified with imaging contrast agents that selectively 
target certain cells and can be visualised using techniques 
such as magnetic resonance imaging (MRI) [5]. 
The fields of Nanomedicine have developed ever since the 
emergence of nanoparticles. These nanoparticles come in 
various shapes. However, these systems have been chosen for 
their stealth function as they are coated with particular lipids, 
as found in the human body making detection by immune cells 
difficult. These systems include nanocarriers such as 
liposomes, nanoerythrosomes and micelles [6]. However, they 
may sound like the perfect solution but even these polymeric 
nanoparticles are not above recognition and degradation by 
immune cells [7]. This has led to the development of 
biomimetic strategies. They are characterised by the ability to 
bypass the immune system. Biomimetic nanotherapeutics can 
mimic the cells biological characteristics, as the structure of 
the system is designed in such a way that the particle has a 
polymeric core, coated by a lipid membrane. These particles 
are favored in nanomedicine as they are devised with surface 
features that are specific for targeting cells or tissues [8]. 
Current research has shown that biomimicry include particles 
such as erythrocyte membrane particles with a PLGA core, 
magnetic core, and PLGA cores enveloped by a white blood cell 
membranes[9,10,11] .This area is particularly eyed upon as 
very little research has been conducted on this topic. 
Nanosponges 
Nanosponges is a new concept, made of microscopic particles 
with few nanometers wide cavities in which a large variety of 
substances can be encapsulated [12]. Nanosponges are a novel 
class of hyper-crosslinked polymer based colloidal structures 
consisting of solid nanoparticles with size range similar to that 
of the colloidal dispersed phase and nanosized cavities. Well-
known examples of nanosponges are titanium-based 
nanosponges [13]. 
Nanosponge bead could be of 25μm sized spheres which can 
have up to 2,50,000 pores and an average internal pore 
structure equivalent to 10 feet in length and average pore 
volume of about 1 ml/mg. The drug loading capacity of 
nanosponges mainly depends on the degree of crystallization 
[35]. 
Characteristics of Nanosponges [35] 
1. Nanosponges have a range of dimensions (1 μm or less). 
2. They are either in Paracrystalline form or crystal form. 
This depends on the the process conditions of the 
nanosponges. Crystal structure of nanosponges plays a 
very important role in their complexation with drugs. 
Para-crystalline nanosponges have shown various drug 
loading capacities. 
3. They are nontoxic, porous particles. They are insoluble 
in most organic solvents and remain stable at high 
temperatures. 
4. Stable in pH range of 1 to 11. 
5. When dissolved in water, they form clear and opalescent 
suspension. 
6. They are able to capture, transport and selectively 
release of a vast variety of substances, all thanks to their 
3D structure. 
Types of drugs which could be used in Nanosponge: 
[14,15] 
Drugs which are to be incorporated into nanosponges should 
have certain characteristics as mentioned below: 
1. Molecular weight should be between 100 and 400 Da. 
2. Drug molecule should consist of less than five condensed 
rings. 
3. Solubility in water should be less than 10mg/mL. 
4. Melting point of the drug should be below 250°C. 
Application 
Nanosponges for drug delivery 
Owing to their nanoporous structures, nanosponges can carry 
water insoluble drugs. Nanosponge can increase the 
dissolution rate, solubility and stability of drugs, mask 
unpleasant flavours and convert liquid substances to solids. β-
Cyclodextrin based nanosponges are reported to deliver the 
drug to the target site more effectively than direct injection 
[16]. 
Being solid in nature, Nanosponge can be formulated into Oral, 
Parenteral, Topical or Inhalation dosage forms. For the oral 
administration, they could be added into excipients, diluents, 
lubricants and anticaking agents which are suitable for the 
preparation of capsules or tablets [17]. For the parenteral 
administration, they can be simply carried in sterile water, 
saline or other aqueous solutions. As for topical 
administration they can be added into topical hydrogel [18]. 
Topical Agents: 
Due to the prolonged release of the drug, Nanosponge are 
ideal for topical drug delivery as the efficiently retain the drug 
on the skin. Local anesthetics, antifungal and antibiotics are 
among the category of the drugs that can be easily formulated 
into topical nanosponges. Serious side effects are observed 
when active ingredients penetrate into skin when given 
topically. This can be avoided using Nanosponge. It can used in 
gel, lotion, cream, ointment, liquid, or powder [19]. Econazole 
nitrate, an antifungal used topically is available in cream, 
ointment, lotion and solution. Adsorption is not significant 
when econazole nitrate is applied to skin and require high 
concentration of active agents to be incorporated for effective 
therapy. Thus, econazole nitrates Nanosponge were fabricated 
by emulsion solvent diffusion method, and these Nanosponges 
were loaded in hydrogel as a local depot for sustained drug 
release [20]. 
Nanosponge as chemical sensors 
Nanosponges which are the type of “metal oxides” act as a 
chemical sensors, used in highly sensitive detection of 
hydrogen using nanosponge titania. [21] 
Nanosponge as carrier for biocatalyst: 
Nanosponge act as carrier for the delivery of enzymes, 
vaccines, proteins and antibodies for diagnosis purpose [22]. 
Cancer Drug therapy: 
Researchers at Vanderbilt University have developed such 
nanosponges which can be used as a delivery system for 
anticancer drugs to tumors. They claim that the method is 
three to five times more effective at reducing tumor growth 
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than direct injection of the drugs. The tiny nanosponges are 
filled with a drug load and expose a targeting peptide that 
binds to radiation exposed cell surface receptors on the tumor. 
When the sponges encounter tumor cells they attach to the 
surface and are triggered to release their drug. Benefits of 
targeted drug delivery include more effective treatment at the 
same dose and fewer side-effects. [23]. 
Nanosponge in Protein delivery: 
Protein formulation faces a difficulty in maintaining their 
native structure and their long term storage. In the 
nanosponges based approach protein are encapsulated in 
cyclodextrin based poly (amidoamine) nanosponges to 
increase the stability of proteins [23]. 
Conclusions [23] 
To conclude, Nanosponges are those type of drug delivery 
system which have the ability to include either lipophilic or 
hydrophilic drugs and release them in a controlled and 
predictable manner at the target site. They can be 
incorporated in the already preexisting drug dosage forms. It 
envisions reduced side effects, improved stability, increases 
elegance and enhanced formulation flexibility. They can be 
used topically, intravenously and also orally. 
Future Opportunities and Challenges [23] 
Nanoparticles and nanoformulations have been greatly 
appreciated in the field of medicine; and nanoparticulate drug 
delivery systems have still greater potential for many 
applications, including anti□tumour, gene, AIDS and 
radiotherapy in the delivery of proteins, antibiotics, 
virostatics, and vaccines as vesicles to pass the blood - brain 
barrier. 
A nanoparticle proving advantageous regarding drug 
targeting, delivery, and release along with their additional 
potential to combine diagnosis and therapy, is one of the 
major tools in nanomedicine. The main goals are to improve 
their stability in the biological environment, to mediate the 
bio-distribution of active compounds, improve drug loading, 
targeting, transport, release, and interaction with biological 
barriers. The cytotoxicity of nanoparticles or their degradation 
products remains a major problem, and improvements in 
biocompatibility obviously are a main concern of future 
research. 
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